ANNE MITTAL: Open Payments
NPI 1518415843 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$684 in 31 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $684
Food & beverage: $684
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 3 | $90 |
| ABBVIE INC. | 3 | $89 |
| UCB, Inc. | 4 | $78 |
| Axsome Therapeutics, Inc. | 3 | $59 |
| JAZZ PHARMACEUTICALS INC. | 2 | $53 |
| EMD Serono, Inc. | 2 | $45 |
| Lundbeck LLC | 2 | $43 |
| CSL Behring | 2 | $41 |
| ARGENX US, INC. | 1 | $29 |
| Neurocrine BioSciences, Inc. | 1 | $25 |
Products named: PONVORY, BOTOX, VYEPTI, Sunosi, Hizentra, Fintepla, Rystiggo, QULIPTA.
Industry payments across AZ — which companies pay providers there.
